Fiche du document
2015
- doi: 10.1016/j.coi.2015.01.011
- issn: 0952-7915
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.coi.2015.01.011
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25665467
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1879-0372
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_266C11B75B8F3
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Thymus-dependent lymphocytes Thymus-derived cells T lymphocytes Thymus-dependent cellsCiter ce document
E. Lanitis et al., « Targeting the tumor vasculature to enhance T cell activity. », Serveur académique Lausannois, ID : 10.1016/j.coi.2015.01.011
Métriques
Partage / Export
Résumé
T cells play a critical role in tumor immune surveillance as evidenced by extensive mouse-tumor model studies as well as encouraging patient responses to adoptive T cell therapies and dendritic cell vaccines. It is well established that the interplay of tumor cells with their local cellular environment can trigger events that are immunoinhibitory to T cells. More recently it is emerging that the tumor vasculature itself constitutes an important barrier to T cells. Endothelial cells lining the vessels can suppress T cell activity, target them for destruction, and block them from gaining entry into the tumor in the first place through the deregulation of adhesion molecules. Here we review approaches to break this tumor endothelial barrier and enhance T cell activity.